All Case Post Marketing Drug Use Result Survey for Blinatumomab in Japan (20170655) (Blinatumomab All Case PMS Japan)

First published 28/11/2018

Last updated 20/09/2023

EU PAS number:

EUPAS26530

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

Study_20170655_Blinatumomab_Japan_PMS_Protocol_Amgen Format_ver1.0

English (647.7 KB - PDF)View document

Study results

Study results

20170655 ORSR Abstract_Redacted

English (127.45 KB - PDF)View document

Study report

Other information